Healthcare Stocks

Why Aptorum Group (APM) stock jumped 33% today?

 Why Aptorum Group (APM) stock jumped 33% today?

Highlights Aptorum Group has received FDA's Orphan Drug Designation for its SACT-1 drug. The Aptorum stock surged over 33% following the news. The company now plans to file an Investigational New Drug Application to start clinical trials of SA...

Read More...
Why CVS Health (NYSE: CVS) Is On Investors’ Radar This Week?

Why CVS Health (NYSE: CVS) Is On Investors’ Radar This Week?

Summary The stock of CVS Health hit a 52-week high of US$89.64 on Tuesday. Shawn Guertin to replace Eva Boratto to become the company’s new finance chief. CVS Health also reaffirmed its recently upgraded outlook for full-year 2021 earnin...

Read More...
Will Women’s Health Be A Priority In NZ’s Budget 2021? 5-Related NZX Stocks- TRU, OCA, TAH, FPH, and GXH

Will Women’s Health Be A Priority In NZ’s Budget 2021? 5-Related NZX Stocks- TRU, OCA, TAH, FPH, and GXH

  • May 17, 2021 10:37 PM PDT
  • Sonal

With the New Zealand Government due to announce the budget in 2 days, all eyes are set on the areas where investments will be made, and the extent to which, it will fulfil the hopes of Kiwis. In the pre-budget speech on May 4, Finance Minister Grant...

Read More...
Clover Health & Onconova Therapeutics: Two Rising Healthcare Stocks

Clover Health & Onconova Therapeutics: Two Rising Healthcare Stocks

Summary Clover Health posted record revenue growth of US$200.3 million in Q1 of 2021. The stock of Onconova jumped 13.82% from its previous close to US$0.5987 at 11:50 am ET on May 17, ahead of its quarterly earnings report. Technology-based h...

Read More...
BioNTech Stock Jumps 10% After Strong Earnings Report

BioNTech Stock Jumps 10% After Strong Earnings Report

Summary German biotechnology firm BioNTech’s revenues rose to €2.05 billion (US$2.49 billion) in the first quarter of 2021, compared to €27.7 million in the year-ago period. The stock gained more than 310% in the past 12 months,...

Read More...
Why These Three Penny Health Stocks Skyrocket Today?

Why These Three Penny Health Stocks Skyrocket Today?

Summary Cocrystal stock (NASDAQ: COCP) jumped over 147% to US$3.07 at 12:21 pm ET on Tuesday, May 4. BioLineRx stock (NASDAQ:BLRX) soared over 68% to US$5.35 at 1:20 pm ET. Precipio stock (NASDAQ:PRPO) surged 15.52% to US$5.7181 at 2:47 pm ET....

Read More...
Will These Three Healthcare Stocks Double In 2021?

Will These Three Healthcare Stocks Double In 2021?

The pandemic has triggered a flurry of activities in the pharmaceutical sector as companies rush to develop drugs to combat the virus. Following the early stage of drug development, companies are coming up with new medicines that are proving effect...

Read More...
Five Healthcare Stocks That May Benefit From Biden’s Drug Policy

Five Healthcare Stocks That May Benefit From Biden’s Drug Policy

Summary President Biden’s new drug policy gets huge support from lawmakers, cutting across political lines. The policy allows the export of essential medicines and raw materials to friendly countries. US drugmakers are expected to receiv...

Read More...
Crypto Kings: Extraordinary Tale of Coinbase Founders Brian Armstrong, Fred Ehrsam

Crypto Kings: Extraordinary Tale of Coinbase Founders Brian Armstrong, Fred Ehrsam

Source: DSkorynko, Shutterstock Summary Although Coinbase made a smashing debuted on NASDAQ, opening 4% higher than the reference price, the Company had humble beginnings. Co-founders Fred Ehrsam and Brian Armstrong met on Reddit and built the...

Read More...
CDC, FDA Recommend Halting Johnson & Johnson’s One-Shot COVID Vaccine

CDC, FDA Recommend Halting Johnson & Johnson’s One-Shot COVID Vaccine

Source: solarseven, Shutterstock  Shares of Johnson & Johnson (NYSE: JNJ) fell 1.34 percent on Tuesday after the U.S. Centers for Disease Control and Prevention (CDC) and the Food and Drug Administration (FDA) recommended pausing the compan...

Read More...
2 COVID Vaccine Stocks to Watch In 2021

2 COVID Vaccine Stocks to Watch In 2021

Source:solarseven, Shutterstock Summary Moderna anticipates US$18.4 billion in sales from its COVID-19 vaccines in 2021. Pfizer forecasts COVID-19 vaccine revenue in 2021 to hit US$15 billion. Moderna’s stock skyrocketed over 430 percen...

Read More...